Author pages are created from data sourced from our academic publisher partnerships and public sources.
Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study
Background: C-reactive protein (CRP), a marker of systemic inflammation, is a powerful predictor of adverse cardiovascular events. Respiratory impairment is also associated with cardiovascular risk.… Expand
Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications.
About 25% of French hemodialysis patients have antibodies against the hepatitis C virus (HCV), which may reflect either past or active HCV infection. It is important to evaluate the significance of… Expand
Hepatitis C viremia and anti-HCV antibodies in alcoholics.
We determined serum hepatitis C status using a RIBA2 kit and a sensitive PCR procedure in 62 chronic alcoholics, 36 of whom had anti-HCV antibodies (Ab) detectable in an ELISA1 assay. Anti-HCV… Expand
Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens.
In a pilot study, it was established that specific therapy by standard anti-hepatitis B virus (HBV) vaccination may be effective in reducing HBV replication and canceling the immune tolerance to… Expand
Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease.
We conducted a retrospective study in 229 patients to determine the prevalence of hepatitis C virus (HCV) according to the type of liver disease and also the serum hepatitis B virus (HBV) status.… Expand
Persistence of Hepatitis B and Hepatitis C Viral Genomes in Primary Liver Cancers from HBsAg‐Negative Patients: A Study of a Low‐endemic Area
The role of HBV and HCV in the course of primary liver cancer in patients who are negative for HBsAg has been debated. Using a combination of serological and polymerase chain reaction assays, we… Expand
Specific vaccine therapy in chronic hepatitis B infection
Efficacy and limitations of a specific immunotherapy in chronic hepatitis B.
BACKGROUND/AIMS This controlled study aimed to evaluate the efficacy and potential side effects of hepatitis B virus (HBV) vaccination as active immunotherapy in HBV-related chronic hepatitis. … Expand
Immunotherapy of chronic hepatitis B by anti HBV vaccine.
Vaccine therapy is now used in various infectious diseases. The hepatitis B virus (HBV) leads to chronic infection in around 5% of patients with a high risk of chronic active hepatitis which may… Expand
Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis.
Influence of viral liver diseases on the occurrence of azathioprine hepatitis was evaluated in 21 kidney transplant recipients. Diagnosis of azathioprine hepatitis was always based on jaundice, which… Expand